Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Article in English | IMSEAR | ID: sea-64049

ABSTRACT

There is limited information regarding the efficacy of 'directly observed treatment short course' (DOTS) in the treatment of intestinal tuberculosis. We randomized patients with ileocecal or colonic tuberculosis to receive daily tuberculosis chemotherapy (Group A) or DOTS (Group B). Patients received isoniazid, rifampicin, pyrazinamide and ethambutol daily for two months in group A and thrice weekly for 2 months in group B, followed by isoniazid and rifampicin daily for 7 months in group A and thrice weekly for 4 months in group B. Patients were followed up at 2 and 4 weeks and monthly thereafter until the end of treatment. Follow up colonoscopy was done at 2 and 6 months after starting treatment. The improvement in clinical symptoms was not different between Groups A (24) and B (23) at 2 and 6 months. Mean increase in weight was 5.1 (0.5) Kg and 5.7 (0.6) Kg at 2 months and 7.1 (1.7) Kg and 6.9 (1.9) Kg at 6 months in Group A and B, respectively. Complete healing of ulceration was noted in 75% of Group A patients and 79% of Group B patients at 2 months and in all patients in both groups at 6 months. We conclude that DOTS and daily chemotherapy are equally effective for treating ileocecal and colonic tuberculosis.


Subject(s)
Antitubercular Agents/administration & dosage , Cecal Diseases/drug therapy , Colonic Diseases/drug therapy , Directly Observed Therapy , Ileal Diseases/drug therapy , Treatment Outcome , Tuberculosis, Gastrointestinal/drug therapy
2.
The Korean Journal of Gastroenterology ; : 324-327, 2007.
Article in Korean | WPRIM | ID: wpr-177556

ABSTRACT

Henoch-Schonlein purpura (H-S purpura) is a systemic small-vessel vasculitis involving skin, joint, gastrointestinal tract, and kidney. It is characterized by the classic tetrad of abdominal pain, arthralgia, typical rash, and renal involvement. All of these clinical findings can occur in any order and at any time over several days to weeks. Gastrointestinal manifestations such as abdominal pain, melena, or hematochezia occur in 45-85% and preceed skin lesions upto 40% in H-S purpura. However, endoscopically proven gastrointestinal lesion is rare because majority of involved sites are small intestine. We report a case of Henoch-Schonlein purpura with terminal ileal ulcer, healed after treatment with high dose steroid, proven by colonoscopy.


Subject(s)
Adult , Humans , Male , Anti-Inflammatory Agents/therapeutic use , Colonoscopy , Ileal Diseases/drug therapy , Leg/pathology , Prednisolone/therapeutic use , IgA Vasculitis/complications , Ulcer/drug therapy
3.
The Korean Journal of Gastroenterology ; : 283-288, 2003.
Article in Korean | WPRIM | ID: wpr-39902

ABSTRACT

BACKGROUNDS/AIMS: Gastrointestinal decompression by nasogastric or intestinal tubes developed in 1930s has been the only treatment modality for inoperable intestinal obstruction. We hypothesized that the octreotide, a potent inhibitor of intestinal secretion, has a therapeutic potential in intestinal obstruction. METHODS: Forty Sprague-Dawley rats were randomly assigned to four groups. The rats were subjected to complete or partial ileal obstruction. The treated rats received octreotide (100 microgram/kg) while the controls received the same quantity of saline every 12 hours for 24 or 48 hours. After 24 or 48 hours, the volumes of the small bowel contents were measured. The volumes of supernatant and the concentrations of electrolytes in the small bowel contents after centrifugation were also analyzed. The ileal segments proximal to obstruction were harvested, fixed, and stained, and the pathological changes were evaluated with mucosal damage scores. RESULTS: There were no statistical differences in the volume and the electrolyte composition of intestinal fluid among the 4 groups. In the 48 hour complete obstruction group, the octreotide-treated rats showed statistically lower mucosal damage scores than the control rats (p<0.05). CONCLUSIONS: Octreotide exerts mucosal protecting effect on the complete intestinal obstruction rat model.


Subject(s)
Animals , Rats , Gastrointestinal Agents/therapeutic use , Ileal Diseases/drug therapy , Ileum/pathology , Intestinal Obstruction/drug therapy , Octreotide/therapeutic use , Rats, Sprague-Dawley
4.
J Indian Med Assoc ; 1992 Feb; 90(2): 37-9
Article in English | IMSEAR | ID: sea-96844

ABSTRACT

Amongst 50 patients with surgical complications of Ascaris lumbricoides 35 patients (70%) were treated conservatively and 15 patients (30%) required surgical intervention which included squeezing of worms to distal colon, resection and anastomosis of ileum, appendicectomy and peritoneal lavage. Intestinal perforation was observed in 3 cases. Two patients (4%) died because of postoperative complications. Those presenting with subacute intestinal obstruction had no mortality or morbidity. Although a large number of roundworms were seen in the jejunum, the obstruction was generally observed in the distal ileum.


Subject(s)
Anthelmintics/administration & dosage , Ascariasis/drug therapy , Child , Child, Preschool , Humans , Ileal Diseases/drug therapy , Intestinal Diseases, Parasitic/drug therapy , Intestinal Obstruction/drug therapy , Jejunal Diseases/drug therapy , Piperazines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL